Gotowa bibliografia na temat „Acute mountain sickness”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Spis treści
Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Acute mountain sickness”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Artykuły w czasopismach na temat "Acute mountain sickness"
Borowska, Emilia, Emilia Harasim i Katarzyna Van Damme -Ostapowicz. "Acute mountain sickness". Archives of Physiotherapy and Global Researches 18, nr 1 (1.12.2014): 19–22. http://dx.doi.org/10.15442/apgr.18.1.21.
Pełny tekst źródłaPigman, Edwin C. "Acute Mountain Sickness". Sports Medicine 12, nr 2 (sierpień 1991): 71–79. http://dx.doi.org/10.2165/00007256-199112020-00001.
Pełny tekst źródłaTassan Din, Chiara, i Massimo Pesenti Campagnoni. "Acute mountain sickness". Emergency Care Journal 2, nr 4 (9.08.2006): 6. http://dx.doi.org/10.4081/ecj.2006.4.6.
Pełny tekst źródłaMcNeil, Edward L. "Acute Mountain Sickness". Journal of the Royal Society of Medicine 89, nr 6 (czerwiec 1996): 359–60. http://dx.doi.org/10.1177/014107689608900625.
Pełny tekst źródłaGoodman, Benny. "Acute mountain sickness". Practice Nursing 14, nr 8 (sierpień 2003): 374–77. http://dx.doi.org/10.12968/pnur.2003.14.8.11465.
Pełny tekst źródłaMurdoch, David R. "Acute Mountain Sickness". Journal of the Royal Society of Medicine 89, nr 12 (grudzień 1996): 728. http://dx.doi.org/10.1177/014107689608901238.
Pełny tekst źródłaJin, Jill. "Acute Mountain Sickness". JAMA 318, nr 18 (14.11.2017): 1840. http://dx.doi.org/10.1001/jama.2017.16077.
Pełny tekst źródłaMurdoch, David R., i Andrew J. Pollard. "Acute Mountain Sickness". Journal of Travel Medicine 4, nr 2 (1.06.1997): 90–93. http://dx.doi.org/10.1111/j.1708-8305.1997.tb00786.x.
Pełny tekst źródłaJohnson, T. Scott, i Paul B. Rock. "Acute Mountain Sickness". New England Journal of Medicine 319, nr 13 (29.09.1988): 841–45. http://dx.doi.org/10.1056/nejm198809293191306.
Pełny tekst źródłaWright, A. D., i R. F. Fletcher. "Acute mountain sickness." Postgraduate Medical Journal 63, nr 737 (1.03.1987): 163–64. http://dx.doi.org/10.1136/pgmj.63.737.163.
Pełny tekst źródłaRozprawy doktorskie na temat "Acute mountain sickness"
Hieronymus, Mathias. "THE EFFECTS OF CARDIORESPIRATORY FITNESS ON SYMPTOMS OF ACUTE MOUNTAIN SICKNESS". Miami University / OhioLINK, 2009. http://rave.ohiolink.edu/etdc/view?acc_num=miami1249835075.
Pełny tekst źródłaWang, Pei. "Genetic association studies of the susceptibility to acute mountain sickness". Thesis, University of British Columbia, 2013. http://hdl.handle.net/2429/44545.
Pełny tekst źródłaKnott, Jonathan R. "Arterial Oxygen Saturation as a Predictor of Acute Mountain Sickness and Summit Success among Mountianeers". DigitalCommons@USU, 2010. https://digitalcommons.usu.edu/etd/674.
Pełny tekst źródłaNybäck, Linn. "Spirometry before high altitude exposure: a way to predict an individual risk of developing acute mountain sickness". Thesis, Mittuniversitetet, Institutionen för hälsovetenskap, 2014. http://urn.kb.se/resolve?urn=urn:nbn:se:miun:diva-22182.
Pełny tekst źródłaMacInnis, Martin J. "Understanding the variable human response to hypoxia : physiological, genetic, and epidemiological investigations of acute mountain sickness susceptibility". Thesis, University of British Columbia, 2014. http://hdl.handle.net/2429/50106.
Pełny tekst źródłaEducation, Faculty of
Kinesiology, School of
Graduate
Evans, Kevin Andrew. "Hypoxia and vascular nitric oxide bioavailability : implications for the pathophysiology of high-altitude illness". Thesis, University of South Wales, 2009. https://pure.southwales.ac.uk/en/studentthesis/hypoxia-and-vascular-nitric-oxide-bioavailability(3cd64bcd-5fb9-4209-a6f3-ab219e906a17).html.
Pełny tekst źródłaJohnson, Pamela Lesley. "Sleep and Breathing at High Altitude". University of Sydney, 2008. http://hdl.handle.net/2123/3531.
Pełny tekst źródłaThis thesis describes the work carried out during four treks, each over 10-11 days, from 1400m to 5000m in the Nepal Himalaya and further work performed during several two-night sojourns at the Barcroft Laboratory at 3800m on White Mountain in California, USA. Nineteen volunteers were studied during the treks in Nepal and seven volunteers were studied at White Mountain. All subjects were normal, healthy individuals who had not travelled to altitudes higher than 1000m in the previous twelve months. The aims of this research were to examine the effects on sleep, and the ventilatory patterns during sleep, of incremental increases in altitude by employing portable polysomnography to measure and record physiological signals. A further aim of this research was to examine the relationship between the ventilatory responses to hypoxia and hypercapnia, measured at sea level, and the development of periodic breathing during sleep at high altitude. In the final part of this thesis the possibility of preventing and treating Acute Mountain Sickness with non-invasive positive pressure ventilation while sleeping at high altitude was tested. Chapter 1 describes the background information on sleep, and breathing during sleep, at high altitudes. Most of these studies were performed in hypobaric chambers to simulate various high altitudes. One study measured sleep at high altitude after trekking, but there are no studies which systematically measure sleep and breathing throughout the whole trek. Breathing during sleep at high altitude and the physiological elements of the control of breathing (under normal/sea level conditions and under the hypobaric, hypoxic conditions present at high altitude) are described in this Chapter. The occurrence of Acute Mountain Sickness (AMS) in subjects who travel form near sea level to altitudes above 3000m is common but its pathophysiology not well understood. The background research into AMS and its treatment and prevention are also covered in Chapter 1. Chapter 2 describes the equipment and methods used in this research, including the polysomnographic equipment used to record sleep and breathing at sea level and the high altitude locations, the portable blood gas analyser used in Nepal and the equipment and methodology used to measure each individual’s ventilatory response to hypoxia and hypercapnia at sea level before ascent to the high altitude locations. Chapter 3 reports the findings on the changes to sleep at high altitude, with particular focus on changes in the amounts of total sleep, the duration of each sleep stage and its percentage of total sleep, and the number and causes of arousals from sleep that occurred during sleep at increasing altitudes. The lightest stage of sleep, Stage 1 non-rapid eye movement (NREM) sleep, was increased, as expected with increases in altitude, while the deeper stages of sleep (Stages 3 and 4 NREM sleep, also called slow wave sleep), were decreased. The increase in Stage 1 NREM in this research is in agreement with all previous findings. However, slow wave sleep, although decreased, was present in most of our subjects at all altitudes in Nepal; this finding is in contrast to most previous work, which has found a very marked reduction, even absence, of slow wave sleep at high altitude. Surprisingly, unlike experimental animal studies of chronic hypoxia, REM sleep was well maintained at all altitudes. Stage 2 NREM and REM sleep, total sleep time, sleep efficiency and spontaneous arousals were maintained at near sea level values. The total arousal index was increased with increasing altitude and this was due to the increasing severity of periodic breathing as altitude increased. An interesting finding of this research was that fewer than half the periodic breathing apneas and hypopneas resulted in arousal from sleep. There was a minor degree of upper airway obstruction in some subjects at sea level but this was almost resolved by 3500m. Chapter 4 reports the findings on the effects on breathing during sleep of the progressive increase of altitude, in particular the occurrence of periodic breathing. This Chapter also reports the results of changes to arterial blood gases as subjects ascended to higher altitudes. As expected, arterial blood gases were markedly altered at even the lowest altitude in Nepal (1400m) and this change became more pronounced at each new, higher altitude. Most subjects developed periodic breathing at high altitude but there was a wide variability between subjects as well as variability in the degree of periodic breathing that individual subjects developed at different altitudes. Some subjects developed periodic breathing at even the lowest altitude and this increased with increasing altitude; other subjects developed periodic breathing at one or two altitudes, while four subjects did not develop periodic breathing at any altitude. Ventilatory responses to hypoxia and hypercapnia, measured at sea level before departure to high altitude, was not significantly related to the development of periodic breathing when the group was analysed as a whole. However, when the subjects were grouped according to the steepness of their ventilatory response slopes, there was a pattern of higher amounts of periodic breathing in subjects with steeper ventilatory responses. Chapter 5 reports the findings of an experimental study carried out in the University of California, San Diego, Barcroft Laboratory on White Mountain in California. Seven subjects drove from sea level to 3800m in one day and stayed at this altitude for two nights. On one of the nights the subjects slept using a non-invasive positive pressure device via a face mask and this was found to significantly improve the sleeping oxyhemoglobin saturation. The use of the device was also found to eliminate the symptoms of Acute Mountain Sickness, as measured by the Lake Louise scoring system. This finding appears to confirm the hypothesis that lower oxygen saturation, particularly during sleep, is strongly correlated to the development of Acute Mountain Sickness and may represent a new treatment and prevention strategy for this very common high altitude disorder.
Nespoulet, Hugo. "Oxygénation en conditions hypoxiques : rôle de la chémosensibilité sur la tolérance à l'altitude, plasticité et amélioration par pression positive expiratoire". Thesis, Grenoble, 2011. http://www.theses.fr/2011GRENS041/document.
Pełny tekst źródłaAt awakening and during sleep, at sea level or in high altitude, maintaining a high level in arterial blood oxygenation is a marker for an adaptated physiological response external and internal factors.High altitude illness encompasses pathologies, that sometimes could be fatal, and which seems to be correlated with the level of arterial oxygenation in hypoxia.Secondly, at sea level and in general population, the high prevalence of obstructive sleep apnea syndrome (OSAS) encourage scientists to develop new models for studying consequences of the main OSAS' stimulus: intermittent hypoxia.Chemosensitivity could play an important role in those two different diseases, with regulation of blood gases and homeostasis by controlling ventilation.Our objectives was to investigate (1) impact of chemosensitivity on blood oxygenation and tolerance to high altitude, comparatively to other physiological factors commonly involved, (2) effects of using positive expiratory pressure in order to improve oxygenation in hypoxia, and (3) consequences of chronic exposure to nocturnal intermittent hypoxia on chemoreflexe plasticity.We found that peripheral chemoresponse to hypoxia play a crucial role in high altitude illness development. Moreover, this variable seems to be a predictive factor for those diseases. In hypoxic conditions, using a positive expiratory pressure (10 cmH2O) lead to a significant improve in arterial oxygenation, by increasing pulmonary diffusion. Finally, nocturnal intermittent hypoxia induced significant sleep disturbances and major changes in chemoresponse to hypoxia and hypercapnia
Kao, Wei-Chun, i 高偉君. "Acute Mountain Sickness and Oxygen Saturation among Jade Mountain Climbers of Taiwan". Thesis, 2003. http://ndltd.ncl.edu.tw/handle/04993094368813127675.
Pełny tekst źródła國立臺灣大學
預防醫學研究所
91
Background As number of trekkers for high-altitude mountain have increased over the past decade, an increase of occurrence of acute mountain sickness (AMS) would be expected. The association between SaO2 and AMS by different altitude was never reported before in Taiwan. Objective The aim of this study was to estimate prevalence rate by different altitude, to elucidate the association between SaO2 and AMS, and finally to develop predictive model for AMS. Methods A total of 26 mountaineers on the pursuit of peak of Jade Mountain between fifteenth November and seventeenth November, 2002 were used as our study subjects. A prospective study design was devised to collect basic characteristics, SaO2 and questionnaire related to AMS. The level of SaO2 was measured nine times at different huts and seal-level with oximeter. We used Lake Louise AMS questionnaire for defining AMS. There are two definitions for AMS. The first type, AMS-1 was defined as having headache together with one of clinical symptoms. The second type, AMS-2 was defined as having three or more clinical symptoms. Those who had symptoms but did not meet the criteria of AMS were referred to as high altitude related symptoms (HARS). At least one of high altitude symptoms occurred was defined as high altitude syndrome (HAS). Predictive models using SaO2 at hut 1 or SaO2 at previous hut as predictor were developed by using logistic regression model. Results At hut 1 (2659m), no HAS and AMS cases were found. At hut 2 (3402m), the prevalence rates of HAS, AMS-1 and AMS-2 were 15.4%, 7.7%, and 7.7%, respectively. The prevalence rates were 65.4%%, 26.9%%, and 30.8% while trekkers climbed to the summit of Jade mountain. The overall prevalence rates were 80.8%, 34.6% and 38.5% for HAS, AMS-1, and AMS-2, respectively, from hut 1 to the summit. The decline in SaO2 at the summit was more remarkable in the HAS group than the normal (p=0.03). The difference in the decline of SaO2 between the AMS-1 group and the control group was borderline statistical significance (p=0.07). No remarkable difference was found between the AMS-2 and the normal group. The differences in the decline of SaO2 were even more pronounced on the descent of hut 2 for the HAS group (p < 0.01) and the AMS-1 group (p=0.03) but not so remarkable for the AMS-2 group (p=0.13). Predictive model using SaO2 at previous hut can significantly account for occurrence of HAS, AMS-1 and AMS-2. Conclusions The association between SaO2 and HAS or AMS by different altitudes was demonstrated. Both the predictive models using SaO2 at baseline or SaO2 at previous hut were also developed. These predictive models may be useful for reducing AMS.
Lee, Mao-Lung, i 李茂榮. "A Study of Acute Mountain Sickness Emergency Care in Tibet Tourism". Thesis, 2017. http://ndltd.ncl.edu.tw/handle/16094147441472543896.
Pełny tekst źródła萬能科技大學
經營管理研究所在職專班
105
The biggest, sometimes fatal, risk for travelling in Tibet is altitude sickness (a.k.a. acute mountain sickness, AMS). When it occurs, the patient not only has to be sent to hospital immediately, but also need to be observed to see if returning to lower altitude areas is necessary. This paper focuses on the risk management for AMS, including setting up a SOP to deal with AMS situation, and prevention measures to reduce the impact of AMS. After all, human life is beyond value. If travelling in Tibet is always threatened by high-risk danger and potential physical impairment, the tourism market will eventually shrink under the shadow. The observation on high altitude (above 2,000 meters) tourism groups indicates that tourists will have different symptoms and severity level of AMS along with the rising of altitude and decreasing of air pressure and oxygen amount. Climate and temperature are also contributing factors to AMS severity. Among those tourists, about 40% have light reaction in the beginning, and 35% of the patients are reported to have reduced symptoms after given medical treatment. However, approximate 5% of them will turn out to suffer from more severe AMS symptoms, including Pulmonary edema (HAPE) or Cerebral edema (HACE), due to lacking of or delayed medical care. And approximate 2% of those severe patients, the symptoms were combined with multiple-organ dysfunctions. At this critical moment, if the patient continues to stay in high altitude area, the medical treatment will be in vain, the possibility to incur multiple organ dysfunction syndromes (MODS) becomes much higher, which leads to a life-threatening situation. In consideration of this, this paper studies how to incorporate current medical and rescue resource system, in order to establish an “AMS Emergency and Medical Assistance Center” in Tibet. This center will be based on local medical staff that has rich experience on AMS medical and caring treatment in Tibet and equipped with private transport vehicles, in order to coordinate and assist overseas rescue organization for transporting patients. And with communication facility, they will be able to conduct distant consultation on medical and nursing to shorten rescue time. AMS should be taken more seriously at the onset of slight symptom and the passenger needs treatments in time. If the symptoms progress to severe situation, the patient needs to be transported to lower altitude areas. The medical process relies on the cooperation and support from associated organizations to enable overall supporting system: The first issue to address is how to require the support from the emergency unit of local hospitals and the agreement of doctors, in order to provide necessary assistance in discharging and transporting the patient to low altitude area, under the supervision of accompanying doctors and nurses along the way. For expense which might incur, there should be an agreement with insurance companies to activate their medical assistance service for overseas emergency medical transport. In the meanwhile, build a bridge between overseas rescue company (also called SOS company) in charge and the transporting company, for the latter to take over the arrangement of a charter flight. The charter flight will carry a professional medical team (doctors and nurses) with necessary medical equipment to provide treatments and transport service for the patient. The paper suggests a model of Emergency and Medical Assistance Center containing the following aspects: Build up an emergency medical and care system Look for local clinics and professional physician for cooperation Build up a reporting platform for emergency medical assistance Purchase an well-equipped ambulance Set up a long-distances communication facility and provide training to emergency medical assistance staff UIA (Union International Assistance) Coordinate with Tibetan tourists for them to be insured by the same insurance company for process convenience. Cope with the exclusive terms of insurance policy Promote a stationed charter flight for medical purpose at Lhasa airport. Make and print manuals of “SOP for medical and emergency assistance during travel”Promote security education for “High Plateau travelling precautions and AMS prevention” Tibetan Travel Emergency and Medical Assistance Center is implemented in the following sequence: Build up an Emergency and Medical Assistance Center. Examine passenger’s physical condition against AMS.Promote the consultancy service of associate doctors or nurses while travelling.Build up a reporting platform for emergency assistance.Establish a coordinating center for long-distance medical treatments.Promote the service system for medical transport of critically-ill patients to low altitude areas. Through the study of a series of documents and local medical culture, experience sharing from first-aid doctors and medical professionals, in-depth interviews with senior travel agents and tour group leads, this paper aims to build up a medical assistance model for AMS, and enable an working model for overseas medical transport system. With the study of this paper, we hope to facilitate the establishment and management of Emergency and Medical Assistance Center, in order to benefit the tourism in high altitude areas such as Taiwan and Tibet, ensuring the travelers to start their journey with a happy mood, and come back home safe and sound. We believe the Overseas Assistance model and Emergency and Medical Assistance Center developed by this paper will be highly welcome by travel agents who share the tourism business in high altitude areas. With the system provided in this paper, high altitude tourism might greets its era with low (or zero) risk.
Książki na temat "Acute mountain sickness"
Grissom, Colin Kerst. Acetazolamide in the treatment of acute mountain sickness: Clinical efficacy and effect on gas exchange. [New Haven :bs.n.], 1990.
Znajdź pełny tekst źródłaMartin, Daniel S., i Michael P. W. Grocott. Pathophysiology and management of altitude-related disorders. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199600830.003.0350.
Pełny tekst źródłaNussbaumer-Ochsner, Yvonne, i Konrad E. Bloch. Sleep at high altitude and during space travel. Redaktorzy Sudhansu Chokroverty, Luigi Ferini-Strambi i Christopher Kennard. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199682003.003.0054.
Pełny tekst źródłaCzęści książek na temat "Acute mountain sickness"
Oette, Mark, Marvin J. Stone, Hendrik P. N. Scholl, Peter Charbel Issa, Monika Fleckenstein, Steffen Schmitz-Valckenberg, Frank G. Holz i in. "Mountain Sickness, Acute". W Encyclopedia of Molecular Mechanisms of Disease, 1351–53. Berlin, Heidelberg: Springer Berlin Heidelberg, 2009. http://dx.doi.org/10.1007/978-3-540-29676-8_3228.
Pełny tekst źródłaBöning, Dieter, Michael I. Lindinger, Damian M. Bailey, Istvan Berczi, Kameljit Kalsi, José González-Alonso, David J. Dyck i in. "Acute Mountain Sickness". W Encyclopedia of Exercise Medicine in Health and Disease, 8–13. Berlin, Heidelberg: Springer Berlin Heidelberg, 2012. http://dx.doi.org/10.1007/978-3-540-29807-6_4.
Pełny tekst źródłaScharnagl, Hubert, Winfried März, Markus Böhm, Thomas A. Luger, Federico Fracassi, Alessia Diana, Thomas Frieling i in. "Acute Mountain Sickness". W Encyclopedia of Molecular Mechanisms of Disease, 30. Berlin, Heidelberg: Springer Berlin Heidelberg, 2009. http://dx.doi.org/10.1007/978-3-540-29676-8_9013.
Pełny tekst źródłaOelz, O. "Prophylaxis and Treatment of Acute Mountain Sickness". W Travel Medicine, 450–56. Berlin, Heidelberg: Springer Berlin Heidelberg, 1989. http://dx.doi.org/10.1007/978-3-642-73772-5_99.
Pełny tekst źródłaVann, Richard D., Neal W. Pollock, Carl F. Pieper, David R. Murdoch, Stephen R. Muza, Michael J. Natoli i Luke Y. Wang. "Epidemiological Modeling of Acute Mountain Sickness (AMS)". W Advances in Experimental Medicine and Biology, 355–58. Boston, MA: Springer US, 2003. http://dx.doi.org/10.1007/978-1-4419-8997-0_25.
Pełny tekst źródłaHackett, Peter H. "High Altitude Cerebral Edema and Acute Mountain Sickness". W Advances in Experimental Medicine and Biology, 23–45. Boston, MA: Springer US, 1999. http://dx.doi.org/10.1007/978-1-4615-4711-2_2.
Pełny tekst źródłaKumar, Kushal, Kalpana Kumari Barwal i Sunil Kumar Hota. "Pathophysiology and Management of Acute Mountain Sickness (AMS)". W The Therapeutic Properties of Medicinal Plants, 167–84. Series statement: Innovations in plant science for better health: from soil to fork: Apple Academic Press, 2019. http://dx.doi.org/10.1201/9780429265204-8.
Pełny tekst źródłaBärtsch, Peter, i Damian Miles Bailey. "Acute Mountain Sickness and High Altitude Cerebral Oedema". W High Altitude, 379–403. New York, NY: Springer New York, 2013. http://dx.doi.org/10.1007/978-1-4614-8772-2_20.
Pełny tekst źródłaMathew Kinsey, C., i Robert Roach. "Role of Cerebral Blood Volume in Acute Mountain Sickness". W Advances in Experimental Medicine and Biology, 151–59. Boston, MA: Springer US, 2003. http://dx.doi.org/10.1007/978-1-4419-8997-0_11.
Pełny tekst źródłaNaeije, Robert, i Aurelie van Osta. "Altered Autoregulation Of Cerebral Blood Flow In Hypoxia: Relevance To The Pathophysiology Of Acute Mountain Sickness". W Problems of High Altitude Medicine and Biology, 211–20. Dordrecht: Springer Netherlands, 2007. http://dx.doi.org/10.1007/978-1-4020-6300-8_15.
Pełny tekst źródłaStreszczenia konferencji na temat "Acute mountain sickness"
Yan, Tzu-Hao, Hsing-Fang Tsai, Sih-Yin Lu, Ching-Shuen Chen, Shih-Tsang Tang i Jiun-Hung Lin. "Portable oximeter for acute mountain sickness". W 2010 International Conference on Electronics and Information Engineering (ICEIE 2010). IEEE, 2010. http://dx.doi.org/10.1109/iceie.2010.5559839.
Pełny tekst źródłaCôrte, Ana Carolina, Roberto Nahon, Breno Schor, Felipe Hardt i Rodrigo Sasson. "357 Can ibuprofen prevent acute mountain sickness in moderate altitude?" W IOC World Conference on Prevention of Injury & Illness in Sport 2021. BMJ Publishing Group Ltd and British Association of Sport and Exercise Medicine, 2021. http://dx.doi.org/10.1136/bjsports-2021-ioc.324.
Pełny tekst źródłaLiu, Zeng Fang, Xing Jia Wei, Fang Fang Liu i Dian Jun Lu. "Evaluation Model of Acute Mountain Sickness Based on item Response Theory". W 2019 10th International Conference on Information Technology in Medicine and Education (ITME). IEEE, 2019. http://dx.doi.org/10.1109/itme.2019.00039.
Pełny tekst źródłaFurian, Michael, Maamed Mademilov, Ainura Abdraeva, Mona Lichtblau, Ulan Sheraliev, Nuriddin H. Marazhapov, Aline Buergin i in. "Acetazolamide for Preventing Acute Mountain Sickness in Healthy Older than 40 years. RCT". W ERS International Congress 2021 abstracts. European Respiratory Society, 2021. http://dx.doi.org/10.1183/13993003.congress-2021.pa749.
Pełny tekst źródłaGopal, Muralikrishna, i Thomas E. Aldrich. "Prediction Of Acute Mountain Sickness (AMS) Based On Pulse Oximetry Measurements During Mt. Kilimanjaro Ascent". W American Thoracic Society 2011 International Conference, May 13-18, 2011 • Denver Colorado. American Thoracic Society, 2011. http://dx.doi.org/10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a4787.
Pełny tekst źródłaVinnikov, Denis, Paul Blanc, Nurlan Brimkulov i Craig Steinmaus. "LATE-BREAKING ABSTRACT: Meta-analysis of the risk of acute mountain sickness from cigarette smoking". W Annual Congress 2015. European Respiratory Society, 2015. http://dx.doi.org/10.1183/13993003.congress-2015.oa2910.
Pełny tekst źródłaChen, Jing, Yuan Tian, Guangbo Zhang, Zhengtao Cao, Lingling Zhu i Dawei Shi. "IoT-enabled Intelligent Dynamic Risk Assessment of Acute Mountain Sickness Based on Data from Wearable Devices". W 2021 4th IEEE International Conference on Industrial Cyber-Physical Systems (ICPS). IEEE, 2021. http://dx.doi.org/10.1109/icps49255.2021.9468233.
Pełny tekst źródłaHamzah, Azham Afzanizam, Abdul Hafidz Hj Omar, Anuar Suun i Dayang Hjh Tiawa Awang Hj Hamid. "ACUTE MOUNTAIN SICKNESS PREDICTION USING PERIPHERAL CAPILLARY OXYGEN SATURATION (SPO2) DEVICE AND LAKE LOUIS SELF-ASSESMENT AMONG MALAYSIAN EVEREST CLIMBERS". W Movement, Health and Exercise 2014 Conference. Universiti Malaysia Pahang, 2014. http://dx.doi.org/10.15282/mohe.2014.sms.083.
Pełny tekst źródłaLuo, Xiaomin, Lei Wang i Lei Yang. "Influence of Induced Altitude Acclimatization on Development of Acute Mountain Sickness Associated with a Subsequent Rapid Ascent to High Altitude". W 2016 IEEE 16th International Conference on Bioinformatics and Bioengineering (BIBE). IEEE, 2016. http://dx.doi.org/10.1109/bibe.2016.41.
Pełny tekst źródłaRaporty organizacyjne na temat "Acute mountain sickness"
Giorgio Manferdelli, Giorgio Manferdelli. Can people be screened for acute mountain sickness susceptibility? Experiment, marzec 2019. http://dx.doi.org/10.18258/13160.
Pełny tekst źródłaMuza, S. R., D. Kaminsky, C. S. Fulco, L. E. Banderet i A. Cymerman. Cysteinyl Leukotriene Blockade Does Not Prevent Acute Mountain Sickness. Fort Belvoir, VA: Defense Technical Information Center, maj 2004. http://dx.doi.org/10.21236/ada423394.
Pełny tekst źródłaRoach, Robert. Prediction of Acute Mountain Sickness using a Blood-Based Test. Fort Belvoir, VA: Defense Technical Information Center, styczeń 2013. http://dx.doi.org/10.21236/ada612856.
Pełny tekst źródłaRoach, Robert. Prediction of Acute Mountain Sickness using a Blood-Based Test. Fort Belvoir, VA: Defense Technical Information Center, styczeń 2015. http://dx.doi.org/10.21236/ada624167.
Pełny tekst źródłaMuza, Stephen R., Paul B. Rock, Timothy Lyons, Charles S. Fulco i Beth A. Beidleman. Susceptibility to Acute Mountain Sickness: Relationship to Pre-Ascent Resting Ventilation. Fort Belvoir, VA: Defense Technical Information Center, maj 2000. http://dx.doi.org/10.21236/ada377573.
Pełny tekst źródłaLovering, Andrew T. Prediction of Susceptibility to Acute Mountain Sickness Using Hypoxia-Induced Intrapulmonary Arteriovenous Shunt and Intracardiac Shunt Fractions. Fort Belvoir, VA: Defense Technical Information Center, październik 2012. http://dx.doi.org/10.21236/ada612590.
Pełny tekst źródłaLovering, Andrew. Prediction of Susceptibility to Acute Mountain Sickness Using Hypoxia-Induced Intrapulmonary Arteriovenous Shunt and Intracardiac Shunt Fractions. Fort Belvoir, VA: Defense Technical Information Center, październik 2013. http://dx.doi.org/10.21236/ada612591.
Pełny tekst źródłaFulco, Charles S., Laurie A. Trad, Vincent A. Forte, Gonzalez Jr., Iwanyk Julio i Eugene J. The Use of Hypoxic and Carbon Dioxide Sensitivity Tests of Predict the Incidence and Severity of Acute Mountain Sickness in Soldiers Exposed to an Elevation of 3800 Meters. Fort Belvoir, VA: Defense Technical Information Center, luty 1991. http://dx.doi.org/10.21236/ada241792.
Pełny tekst źródła